Trademark: 79132921
Word
TETRAVARINEX
Status
Dead
Status Code
709
Status Date
Friday, February 26, 2021
Serial Number
79132921
Registration Number
4582222
Registration Date
Tuesday, August 12, 2014
Mark Type
4000
Filing Date
Thursday, May 30, 2013
Published for Opposition
Tuesday, May 27, 2014
Cancellation Date
Friday, February 26, 2021

Trademark Owner History
GW Research Limited -
GW Pharma Limited - Original Registrant

Classifications
5 Pharmaceutical and veterinary pharmaceutical preparations, namely, herbs, herbal extracts, formulas containing herbal extracts, medicinal oils and pure extracts of medicinal plants and herbs, for use in the treatment of pain, multiple sclerosis, neuropathic pain, spinal cord injury, bladder disfunction, peripheral neuropathy, cancer pain, peri-operative pain, rheumatoid arthritis, inflammatory bowel disease, neurogenic symptoms, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, epilepsy, dravet syndrome, neonatal hypoxia, seizures, alzheimers, bone disorders, drug, alcohol and nicotine abuse, inflammatory disorders, protection of pancreatic islet cells in the treatment of diabetic or pre-diabetic patients, protection of beta cells in the treatment of diabetic or pre-diabetic patients, maintenance of insulin levels, improved control of blood glucose levels, treatment of type I diabetes, treatment of type II diabetes; pharmaceutical and veterinary pharmaceutical preparations for the treatment of pain, multiple sclerosis, neuropathic pain, spinal cord injury, bladder disfunction, peripheral neuropathy, cancer pain, peri-operative pain, rheumatoid arthritis, inflammatory bowel disease, neurogenic symptoms, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, epilepsy, dravet syndrome, neonatal hypoxia, seizures, alzheimers, bone disorders, drug, alcohol and nicotine abuse, inflammatory disorders, protection of pancreatic islet cells in the treatment of diabetic or pre-diabetic patients, protection of beta cells in the treatment of diabetic or pre-diabetic patients, maintenance of insulin levels, improved control of blood glucose levels, treatment of type I diabetes, treatment of type II diabetes; herbs for medicinal purposes; herb teas for medicinal purposes; plant extracts for pharmaceutical purposes

Trademark Events
Jan 30, 2023
Total Invalidation Processed By The Ib
Dec 28, 2022
Total Invalidation Of Reg Ext Protection Sent To Ib
Dec 28, 2022
Invalidation Processed
Nov 24, 2021
New Representative At Ib Received
Oct 26, 2021
Total Invalidation Of Reg Ext Protection Created
Feb 26, 2021
Cancelled Section 71
Oct 9, 2019
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Aug 12, 2019
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Sep 13, 2018
Change Of Owner Received From Ib
Dec 21, 2017
New Representative At Ib Received
Nov 29, 2017
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 29, 2017
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 15, 2016
International Registration Renewed
Sep 24, 2015
Total Invalidation Processed By The Ib
Jun 19, 2015
Change Of Name/Address Rec'd From Ib
Jan 30, 2015
Final Decision Transaction Processed By Ib
Jan 6, 2015
Final Disposition Notice Sent To Ib
Jan 6, 2015
Final Disposition Processed
Nov 12, 2014
Final Disposition Notice Created, To Be Sent To Ib
Aug 12, 2014
Registered-Principal Register
Jun 13, 2014
Notification Processed By Ib
May 27, 2014
Official Gazette Publication Confirmation E-Mailed
May 27, 2014
Published For Opposition
May 7, 2014
Notification Of Possible Opposition Sent To Ib
May 7, 2014
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
May 7, 2014
Notification Of Notice Of Publication E-Mailed
Apr 22, 2014
Withdrawn From Pub - Esu Supervisor Request
Apr 22, 2014
Law Office Publication Review Completed
Apr 18, 2014
Assigned To Lie
Mar 28, 2014
Approved For Pub - Principal Register
Mar 24, 2014
Teas/Email Correspondence Entered
Mar 24, 2014
Correspondence Received In Law Office
Mar 24, 2014
Teas Response To Office Action Received
Jan 2, 2014
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 2, 2014
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 20, 2013
Refusal Processed By Ib
Sep 25, 2013
Non-Final Action Mailed - Refusal Sent To Ib
Sep 25, 2013
Refusal Processed By Mpu
Sep 24, 2013
Non-Final Action (Ib Refusal) Prepared For Review
Sep 23, 2013
Non-Final Action Written
Sep 15, 2013
Assigned To Examiner
Jul 26, 2013
Application Filing Receipt Mailed
Jul 22, 2013
New Application Office Supplied Data Entered
Jul 18, 2013
Sn Assigned For Sect 66a Subseq Desig From Ib

Trademark Alertz updated from USPTO on 2030-01-24